ProKidney Corp.
PROK
$2.28
$0.031.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.50% | 1.09% | 21.36% | -18.81% | -43.21% |
| Total Depreciation and Amortization | 14.20% | -8.44% | 1.65% | 5.92% | 17.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.25% | 7.28% | 29.29% | -75.50% | 35.77% |
| Change in Net Operating Assets | 168.85% | -269.90% | -93.66% | 6,626.02% | 96.42% |
| Cash from Operations | 15.34% | -6.16% | -22.43% | 17.34% | 23.64% |
| Capital Expenditure | -67.00% | -174.19% | 95.55% | -961.11% | -277.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.84% | -26.33% | -27.51% | 151.23% | -371.28% |
| Cash from Investing | 56.30% | -34.37% | 87.59% | 118.47% | -385.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 135.71% | -16.67% | 14.29% | 0.00% | -7.69% |
| Issuance of Common Stock | -- | -- | -- | -96.94% | -96.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 56,964.29% | -16.67% | -109.76% | -97.24% | -96.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.71% | -878.33% | 85.34% | 91.57% | -181.79% |